|
[1]
|
Fisman DN, Tuite AR. Asymptomatic infection is the pandemic’s dark matter. Proc Natl Acad Sci USA 2021;118(38):e2114054118. http://dx.doi.org/10.1073/pnas.2114054118CrossRef
|
|
[2]
|
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci USA 2020;117(30):17513-5. http://dx.doi.org/10.1073/pnas.2008373117CrossRef
|
|
[3]
|
Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 2022;603(7902):679-86. http://dx.doi.org/10.1038/s41586-022-04411-yCrossRef
|
|
[4]
|
Mena GE, Martinez PP, Mahmud AS, Marquet PA, Buckee CO, Santillana M. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science 2021;372(6545):eabg5298. http://dx.doi.org/10.1126/science.abg5298CrossRef
|
|
[5]
|
Du ZW, Pandey A, Bai Y, Fitzpatrick MC, Chinazzi M, Piontti APY, et al. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. Lancet Public Health 2021;6(3):e184-91. http://dx.doi.org/10.1016/S2468-2667(21)00002-5CrossRef
|
|
[6]
|
Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis 2020;20(10):1151-60. http://dx.doi.org/10.1016/S1473-3099(20)30457-6CrossRef
|
|
[7]
|
Hellewell J, Russell TW, The SAFER Investigators and Field Study Team, The Crick COVID-19 Consortium, CMMID COVID-19 Working Group, Beale R, et al. Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections. BMC Med 2021;19(1):106. http://dx.doi.org/10.1186/s12916-021-01982-xCrossRef
|
|
[8]
|
Aleta A, Martín-Corral D, Piontti APY, Ajelli M, Litvinova M, Chinazzi M, et al. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav 2020;4(9):964-71. http://dx.doi.org/10.1038/s41562-020-0931-9CrossRef
|
|
[9]
|
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, et al. Optimal COVID-19 quarantine and testing strategies. Nat Commun 2021;12(1):356. http://dx.doi.org/10.1038/s41467-020-20742-8CrossRef
|
|
[10]
|
Quilty BJ, Clifford S, Hellewell J, Russell TW, Kucharski AJ, Flasche S, et al. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study. Lancet Public Health 2021;6(3):e175-83. http://dx.doi.org/10.1016/S2468-2667(20)30308-XCrossRef
|
|
[11]
|
Elliott J, Whitaker M, Bodinier B, Riley S, Ward H, Cooke G, et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021 Sep 28;18(9):e1003777. http://dx.doi.org/10.1371/journal.pmed.1003777.http://dx.doi.org/10.1371/journal.pmed.1003777 |
|
[12]
|
Pavelka M, Van-Zandvoort K, Abbott S, Sherratt K, Majdan M, CMMID COVID-19 Working Group, et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science 2021;372(6542):635-41. http://dx.doi.org/10.1126/science.abf9648CrossRef
|
|
[13]
|
Wells CR, Pandey A, Moghadas SM, Singer BH, Krieger G, Heron RJL, et al. Comparative analyses of eighteen rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation. Commun Med 2022;2(1):84. http://dx.doi.org/10.1038/s43856-022-00147-yCrossRef
|
|
[14]
|
Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv 2021;7(1):eabd5393. http://dx.doi.org/10.1126/sciadv.abd5393CrossRef
|
|
[15]
|
Cleary B, Hay JA, Blumenstiel B, Harden M, Cipicchio M, Bezney J, et al. Using viral load and epidemic dynamics to optimize pooled testing in resource-constrained settings. Sci Transl Med 2021;13(589):eabf1568. http://dx.doi.org/10.1126/scitranslmed.abf1568CrossRef
|
|
[16]
|
Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020;26(8):1200-4. http://dx.doi.org/10.1038/s41591-020-0965-6CrossRef
|
|
[17]
|
Subramanian R, He QX, Pascual M. Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity. Proc Natl Acad Sci USA 2021;118(9):e2019716118. http://dx.doi.org/10.1073/pnas.2019716118CrossRef
|